Dyne Therapeuticsinc Stock Five Year Return
DYN Stock | USD 28.50 1.72 6.42% |
Dyne TherapeuticsInc fundamentals help investors to digest information that contributes to Dyne TherapeuticsInc's financial success or failures. It also enables traders to predict the movement of Dyne Stock. The fundamental analysis module provides a way to measure Dyne TherapeuticsInc's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Dyne TherapeuticsInc stock.
Dyne | Five Year Return |
Dyne Five Year Return Analysis
Dyne TherapeuticsInc's Five Year Return is considered one of the best measures to evaluate fund performance, especially from the mid and long term perspective. It shows the total annualized return generated from holding equity for the last five years and represents capital appreciation of the investment, including all dividends, losses, and capital gains distributions.
More About Five Year Return | All Equity Analysis
2021 | 2022 | 2023 | 2024 (projected) | Reconciled Depreciation | 1.1M | 1.7M | 1.7M | 997.5K | Research Development | 121.3M | 142.8M | 210.8M | 221.3M |
Five Year Return | = | (Mean of Monthly Returns - 1) | X | 100% |
Dyne Five Year Return Driver Correlations
Understanding the fundamental principles of building solid financial models for Dyne TherapeuticsInc is extremely important. It helps to project a fair market value of Dyne Stock properly, considering its historical fundamentals such as Five Year Return. Since Dyne TherapeuticsInc's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Dyne TherapeuticsInc's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Dyne TherapeuticsInc's interrelated accounts and indicators.
Click cells to compare fundamentals
Although Five Year Returns can give a sense of overall investment potential, it is recommended to compare equity performance with similar assets for the same five year time interval. Similarly, comparing overall investment performance over the last five years with the appropriate market index is a great way to determine how this equity instrument will perform during unforeseen market fluctuations.
Competition |
Dyne Return On Capital Employed
Return On Capital Employed |
|
According to the company disclosure, Dyne TherapeuticsInc has a Five Year Return of 0.0%. This indicator is about the same for the Biotechnology average (which is currently at 0.0) sector and about the same as Health Care (which currently averages 0.0) industry. This indicator is about the same for all United States stocks average (which is currently at 0.0).
Dyne Five Year Return Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Dyne TherapeuticsInc's direct or indirect competition against its Five Year Return to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Dyne TherapeuticsInc could also be used in its relative valuation, which is a method of valuing Dyne TherapeuticsInc by comparing valuation metrics of similar companies.Dyne TherapeuticsInc is currently under evaluation in five year return category among related companies.
Dyne Fundamentals
Return On Equity | -1.37 | ||||
Return On Asset | -0.64 | ||||
Current Valuation | 2.24 B | ||||
Shares Outstanding | 81.96 M | ||||
Shares Owned By Insiders | 0.94 % | ||||
Shares Owned By Institutions | 86.19 % | ||||
Number Of Shares Shorted | 6.82 M | ||||
Price To Earning | 35.58 X | ||||
Price To Book | 25.59 X | ||||
EBITDA | (239.7 M) | ||||
Net Income | (235.94 M) | ||||
Cash And Equivalents | 291.84 M | ||||
Cash Per Share | 5.64 X | ||||
Total Debt | 27.41 M | ||||
Debt To Equity | 0.11 % | ||||
Current Ratio | 11.63 X | ||||
Book Value Per Share | 1.49 X | ||||
Cash Flow From Operations | (188.16 M) | ||||
Short Ratio | 5.27 X | ||||
Earnings Per Share | (3.95) X | ||||
Price To Earnings To Growth | 0.19 X | ||||
Target Price | 37.75 | ||||
Number Of Employees | 141 | ||||
Beta | 0.95 | ||||
Market Capitalization | 2.34 B | ||||
Total Asset | 165.08 M | ||||
Retained Earnings | (632.51 M) | ||||
Working Capital | 78.28 M | ||||
Current Asset | 1.93 B | ||||
Current Liabilities | 809 M | ||||
Z Score | 41.53 | ||||
Net Asset | 165.08 M |
About Dyne TherapeuticsInc Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Dyne TherapeuticsInc's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Dyne TherapeuticsInc using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Dyne TherapeuticsInc based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.Dyne Therapeutics, Inc., a muscle disease company, operates as a biotechnology company that focuses on advancing therapeutics for genetically driven muscle diseases in the United States. The company was incorporated in 2017 and is headquartered in Waltham, Massachusetts.. Dyne Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 108 people.
Pair Trading with Dyne TherapeuticsInc
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Dyne TherapeuticsInc position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dyne TherapeuticsInc will appreciate offsetting losses from the drop in the long position's value.Moving together with Dyne Stock
0.85 | EQ | Equillium Financial Report 9th of May 2024 | PairCorr |
Moving against Dyne Stock
0.88 | KA | Kineta Inc Report 29th of March 2024 | PairCorr |
0.88 | MEIP | MEI Pharma Financial Report 9th of May 2024 | PairCorr |
0.84 | VALN | Valneva SE ADR Financial Report 2nd of May 2024 | PairCorr |
0.78 | MCRB | Seres Therapeutics Financial Report 14th of May 2024 | PairCorr |
0.76 | CALT | Calliditas Therapeutics Financial Report 21st of May 2024 | PairCorr |
The ability to find closely correlated positions to Dyne TherapeuticsInc could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Dyne TherapeuticsInc when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Dyne TherapeuticsInc - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Dyne TherapeuticsInc to buy it.
The correlation of Dyne TherapeuticsInc is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Dyne TherapeuticsInc moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Dyne TherapeuticsInc moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Dyne TherapeuticsInc can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out Dyne TherapeuticsInc Piotroski F Score and Dyne TherapeuticsInc Altman Z Score analysis. To learn how to invest in Dyne Stock, please use our How to Invest in Dyne TherapeuticsInc guide.You can also try the Portfolio Rebalancing module to analyze risk-adjusted returns against different time horizons to find asset-allocation targets.
Complementary Tools for Dyne Stock analysis
When running Dyne TherapeuticsInc's price analysis, check to measure Dyne TherapeuticsInc's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Dyne TherapeuticsInc is operating at the current time. Most of Dyne TherapeuticsInc's value examination focuses on studying past and present price action to predict the probability of Dyne TherapeuticsInc's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Dyne TherapeuticsInc's price. Additionally, you may evaluate how the addition of Dyne TherapeuticsInc to your portfolios can decrease your overall portfolio volatility.
Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
Portfolio Dashboard Portfolio dashboard that provides centralized access to all your investments | |
Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
Equity Analysis Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities | |
Bonds Directory Find actively traded corporate debentures issued by US companies | |
Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges |
Is Dyne TherapeuticsInc's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Dyne TherapeuticsInc. If investors know Dyne will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Dyne TherapeuticsInc listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (3.95) | Return On Assets (0.64) | Return On Equity (1.37) |
The market value of Dyne TherapeuticsInc is measured differently than its book value, which is the value of Dyne that is recorded on the company's balance sheet. Investors also form their own opinion of Dyne TherapeuticsInc's value that differs from its market value or its book value, called intrinsic value, which is Dyne TherapeuticsInc's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Dyne TherapeuticsInc's market value can be influenced by many factors that don't directly affect Dyne TherapeuticsInc's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Dyne TherapeuticsInc's value and its price as these two are different measures arrived at by different means. Investors typically determine if Dyne TherapeuticsInc is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Dyne TherapeuticsInc's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.